Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

National program scale-up and patient outcomes in a pediatric antiretroviral treatment program, Thailand, 2000-2007.

McConnell MS, Chasombat S, Siangphoe U, Yuktanont P, Lolekha R, Pattarapayoon N, Kohreanudom S, Mock PA, Fox K, Thanprasertsuk S.

J Acquir Immune Defic Syndr. 2010 Aug;54(4):423-9. doi: 10.1097/QAI.0b013e3181dc5eb0.

PMID:
20418772
2.

National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes.

Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K, Thanprasertsuk S, Mock PA, Ningsanond P, Lertpiriyasuwat C, Pinyopornpanich S.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):506-12. doi: 10.1097/QAI.0b013e3181967602.

PMID:
19223784
3.

Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces.

Plipat T, Naiwatanakul T, Rattanasuporn N, Sangwanloy O, Amornwichet P, Teeraratkul A, Ungchusak K, Mock P, Levine W, McConnell MS, Simonds R, Culnane M.

AIDS. 2007 Jan 11;21(2):145-51.

PMID:
17197804
4.
5.

Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in lesotho.

Leyenaar JK, Novosad PM, Ferrer KT, Thahane LK, Mohapi EQ, Schutze GE, Kline MW.

Pediatr Infect Dis J. 2010 Apr;29(4):340-5. doi: 10.1097/INF.0b013e3181bf8ecb.

PMID:
20019645
6.

The economics of effective AIDS treatment in Thailand.

Over M, Revenga A, Masaki E, Peerapatanapokin W, Gold J, Tangcharoensathien V, Thanprasertsuk S.

AIDS. 2007 Jul;21 Suppl 4:S105-16.

PMID:
17620745
7.

Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age.

Sauvageot D, Schaefer M, Olson D, Pujades-Rodriguez M, O'Brien DP.

Pediatrics. 2010 May;125(5):e1039-47. doi: 10.1542/peds.2009-1062. Epub 2010 Apr 12.

PMID:
20385636
8.

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524.

PMID:
18199042
9.

Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand.

Sanguanwongse N, Cain KP, Suriya P, Nateniyom S, Yamada N, Wattanaamornkiat W, Sumnapan S, Sattayawuthipong W, Kaewsa-ard S, Ingkaseth S, Varma JK.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):181-9. doi: 10.1097/QAI.0b013e318177594e.

PMID:
18520676
10.

Antiretroviral drug therapy in HIV-infected Jamaican children.

Evans-Gilbert T, Pierre R, Steel-Duncan JC, Rodriguez B, Whorms S, Hambleton IR, Figueroa JP, Christie CD.

West Indian Med J. 2004 Oct;53(5):322-6.

PMID:
15675498
11.

Antiretroviral therapy for children in the routine setting in Malawi.

Malawi Paediatric Antiretroviral Treatment Group.

Trans R Soc Trop Med Hyg. 2007 May;101(5):511-6. Epub 2006 Dec 29.

PMID:
17197006
12.

From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.

Thaineua V, Sirinirund P, Tanbanjong A, Lallemant M, Soucat A, Lamboray JL.

Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):429-42.

PMID:
10437936
13.

Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.

Gaughan DM, Mofenson LM, Hughes MD, Seage GR 3rd, Ciupak GL, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team.

Pediatrics. 2002 May;109(5):E74-4.

PMID:
11986480
14.

The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.

Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ.

Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5.

PMID:
19451858
15.
16.

Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia.

Sutcliffe CG, van Dijk JH, Bolton-Moore C, Cotham M, Tambatamba B, Moss WJ.

Pediatr Infect Dis J. 2010 Sep;29(9):849-54. doi: 10.1097/INF.0b013e3181e753a8.

PMID:
20526227
17.

Characteristics of HIV-infected children seen in Western Kenya.

Nyandiko WM, Mwangi A, Ayaya SO, Nabakwe EC, Tenge CN, Gisore PM, Vreeman RC.

East Afr Med J. 2009 Aug;86(8):364-73.

PMID:
20575310
18.

Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.

Rajasekaran S, Jeyaseelan L, Vijila S, Gomathi C, Raja K.

AIDS. 2007 Jul;21 Suppl 4:S47-53.

PMID:
17620752
19.

The Chinese free antiretroviral treatment program: challenges and responses.

Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, Yu L, Goosby EP.

AIDS. 2007 Dec;21 Suppl 8:S143-8. doi: 10.1097/01.aids.0000304710.10036.2b.

PMID:
18172383
20.

Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya.

Nyandiko WM, Ayaya S, Nabakwe E, Tenge C, Sidle JE, Yiannoutsos CT, Musick B, Wools-Kaloustian K, Tierney WM.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):418-25.

PMID:
17099313

Supplemental Content

Support Center